Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Victor A. Adepoju. Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?. Breathe, 15 (4) 353; 10.1183/20734735.0257-2019

Member's Comments

No comment yet.

Related content which might interest you: Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019 Year: 2019 Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019 Year: 2019 May the value of FEV1 be helpful in the choice of the antibiotic therapy in acute exacerbation of COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 189s Year: 2001 Is antibiotic treatment during asthma exacerbation necessary ? Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Should the number of acute exacerbations in the previous year be used to guide treatments in COPD? Source: Eur Respir J, 57 (2) 2002122; 10.1183/13993003.02122-2020 Year: 2021 Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis Source: Eur Respir Rev 2017; 26: 160073 Year: 2017 Can antibiotics prevent acute COPD exacerbation? A systematic review and meta-analysis Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 What is the role of prophylactic antibiotic therapy in chronic bronchitis or COPD? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009 Antibiotic effectiveness to prevent new chronic obstructive pulmonary disease (COPD) exacerbations in current medical practice Source: Annual Congress 2009 - Functional insights into COPD Year: 2009 COPD: antibiotic strategy in infectious exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 137s Year: 2001 Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD Source: Eur Respir J 2009; 33: 282-288 Year: 2009 Which patients with COPD can potentially benefit from prophylactic use of antibiotics? Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Prudent use of antibiotics: acute exacerbation of COPD as an example Source: Eur Respir J 2010; 36: 983-985 Year: 2010 Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014